La pruvincia dû tumuri dû senu si rifirisci ô risurtatu prividutu o a lu cursu prubbàbbili dâ malatia.
Di sòlitu è ditirminata di fattura comu lu stadiu dû tumuri, lu tipu di tumuri, l'età dû malatu e la saluti ginirali, e l'efficacità dû trattamentu.
Cchiù prestu si scopri e si cura u tumuri dâ mammella, megghiu è a prognosi.
Lu tassu di supravvivenza a cincu anni pi li malati di tumuri di mammariu è di circa lu 90%, ca significa ca lu 90% dî malati di tumuri di mammariu sunnu ancora vivi cincu anni doppu la diagnosi.
Tuttavia, è mpurtanti nutari ca la situazzioni di ogni pirsuna è unica e la pruognosi pò variari assai a secunnu li circustanzi spicìfichi.
McCarthy AM, Manning AK, Hsu S, Welch M, Moy B, Lehman CD, Armstrong K: Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer. Breast Cancer Res Treat. 2022, 196 (2): 389-398.
Han Y, Wang J, Xu B: Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis. Breast. 2020, 54 (): 114-120.
Wang Z, Chen J, Zhong MZ, Huang J, Hu YP, Feng DY, Zhou ZJ, Luo X, Liu ZQ, Jiang WZ, Zhou WB: Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients. Cancer Chemother Pharmacol. 2017, 79 (3): 535-543.
Zhang L, Han L, Huang Y, Feng Z, Wang X, Li H, Song F, Liu L, Li J, Zheng H, Wang P, Song F, Chen K: SNPs within microRNA binding sites and the prognosis of breast cancer. Aging (Albany NY). 2021, 13 (5): 7465-7480.
Li Y, Duan W, Qi Q, Wang T, Yang Q, Du L, Mao H, Wang C: A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer. Cell Death Dis. 2021, 12 (7): 670.
Li N, Li Z, Li X, Chen B, Sun H, Zhao K: Identification of an immune-related long noncoding RNA signature that predicts prognosis in breast cancer patients. Biomark Med. 2021, 15 (3): 167-180.
['Disclaimer: mèdicu']
['Stu situ web è furnutu sulu pi scopi didattici e nfurmativi e nun è nu cunzigghiu medicu o nu sirvizziu prufissiunali.']
['Li nfurmazzioni furniti nun hannu a èssiri usati pi diagnosticari o curari nu prubblema di saluti o na malatia, e chiddi ca cercanu cunsigghi medici pirsunali hannu a cunsultari nu mèdicu.']
["Pi favuri, nota ca la riti neurali ca pruduci risposti ê dumanni è assai nun pricisa quannu si tratta di cuntinutu numèricu, p'asempiu, lu nùmmaru di pirsuni ca hannu na malatìa spicifica."]
['Cercati sempri lu cunsigghiu dû vostru dutturi o di àutru dutturi qualificatu pi na cunnizzioni medica. Nun trascurati mai lu cunsigghiu medicali prufissiunali o ritarda a circallu pi quarchi cosa ca liggisti nta stu situ.']
['Disclaimer: copyright']
['Lu Digital Millennium Copyright Act di 1998, 17 U.S.C. § 512 (lu DMCA) furnisci nu ricorsu pi li pruprietari di copyright ca cridinu ca lu matiriali ca cumpari nta Internet viula li sò diritti sutta la liggi statunitenzi supra lu copyright. ']
["Si ti pari di bona fidi ca nu cuntinutu o matiriali misu a dispusizzioni ntô cuntattu dû nostru situ o dî nostri sirvizzi viula li tò dritti d'auturi, tu (o lu tò agenti) ci poi mannari na nutìfica addumannànnu la rimozzioni dû cuntinutu o dû matiriali o lu bloccu di l'accessu."]
['Li notificazzioni hannu a èssiri mannati pi scrittu pi posta elittrònica (talìa la sizzioni "Cuntattu" pi l\'indirizzu elittrònicu).']
["Lu DMCA richiedi ca la tò nfurmazzioni di na prisunta violazzioni dô copyright ncludissi li nfurmazzioni siquenti: (1) discrizzioni di l'òpira prutiggiuta dô copyright ca è suggetta â prisunta violazzioni; (2) discrizzioni dû cuntinutu prutiggiutu e nfurmazzioni sufficienti pi pirmittirini di lu truvari; (3) nfurmazzioni di cuntattu pi tìa, cumprisi lu tò nnirizzu, nùmmuru di telefunu e nnirizzu email; (4) na dichjarazzioni di tìa ca hai la bona fidi ca lu cuntinutu di cui ti lamenti nun è auturizzatu dû pruprietariu dô copyright, dû sò agenti o di quarchi liggi; "]
["(5) na dichiarazzioni di tìa, firmata sutta pena di spergiuru, ca li nfurmazzioni dâ notifica sunnu accurati e ca hai l'auturitati di fari valiri li diritti d'auturi ca si dici ca sunnu stati viulati;"]
['e (6) na firma fisica o ilittronica dû pruprietariu dô copyright o di na pirsuna auturizzata a agiri ô sò nnomu.']
['Si nun si cuntènunu tutti li nfurmazzioni di supra, lu trattamentu dâ lagnanza putissi ritardari.']
['Cuntattu']
['Pi favuri mannàtimi na mail cu ogni dumanna/suggerimentu.']
What is prognosis of breast cancer?
The prognosis of breast cancer refers to the predicted outcome or likely course of the disease.
It is typically determined by factors such as the stage of the cancer, the type of cancer, the patient's age and overall health, and the effectiveness of treatment.
The earlier breast cancer is detected and treated, the better the prognosis tends to be.
The five-year survival rate for breast cancer patients is around 90%, meaning that 90% of patients diagnosed with breast cancer are still alive five years after their diagnosis.
However, it is important to note that every individual's situation is unique, and the prognosis can vary greatly depending on the specific circumstances.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Circa']
['BioMedLib usa computer autumatizzati (algoritmi di machine learning) pi ginirari coppie di dumanni e risposti.']
['Accuminciamu cu 35 miliuna di pubblicazzioni biumediche di PubMed/Medline.']
